Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor-Reference-Cited by-同舟云学术

Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor

Published:2010-02-19 Issue:3 Volume:28 Page:211-220
ISSN:0897-7194
Container-title:Growth Factors
language:en
Short-container-title:Growth Factors

Author:

Kernt M.,Liegl R. G.,Rueping J.,Neubauer A. S.,Haritoglou C.,Lackerbauer C. A.,Eibl K. H.,Ulbig M. W.,Kampik A.

Publisher

Informa UK Limited

Subject

Cell Biology,Clinical Biochemistry,Endocrinology

Link

http://www.tandfonline.com/doi/pdf/10.3109/08977191003604505

Reference53 articles.

1. Sorafenib (BAY 43‐9006, Nexavar®), a Dual‐Action Inhibitor That Targets RAF/MEK/ERK Pathway in Tumor Cells and Tyrosine Kinases VEGFR/PDGFR in Tumor Vasculature

2. Targeting Intraocular Neovascularization and Edema — One Drop at a Time

3. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

4. Role of platelet-derived growth factors in physiology and medicine

5. Diabetic Retinopathy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies;Pharmaceutics;2023-10-04

2. Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study;Pharmaceutics;2021-11-18

3. Role of glia in optic nerve;Progress in Retinal and Eye Research;2021-03

4. Protective Functions of Reactive Astrocytes Following Central Nervous System Insult;Frontiers in Immunology;2020-09-30

5. Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection;Diabetes Research and Clinical Practice;2020-04